Aipass Biotech Q4 2025 Financial Report
NQ Score
63/100
N1 Content Completeness
8
AI Summary (NQ-processed)
Aipass Biotech (Company Code: 6918) reported strong financial results for Q4 2025, with basic EPS of NT.16, revenue of NT36 million, and net profit after tax of NT70 million.
AI analysis data is not yet available.